Analog Devices Expands AI Capabilities with $1.35 Billion Acquisition of Alif Semiconductor
Analog Devices' $1.35 billion acquisition of Alif Semiconductor could reshape the edge AI chip market.
Roivant Sciences Gains Traction as Mosliciguat Progresses to Phase 3 Trials
Roivant Sciences sees increased investor confidence as it advances mosliciguat to Phase 3 trials, boosted by TD Cowen's price target raise.
Trade with the conviction of the 1%.
Institutional-grade market intelligence delivered before the opening bell.
Brent Crude Hits $100: Implications for US Equity Markets Amid Geopolitical Tensions
Brent crude oil prices soar past $100, raising concerns about US equity markets and consumer behavior amid rising geopol…
Analog Devices Expands Semiconductor Portfolio with $1.35B Acquisition of Alif Semiconductor
Analog Devices' $1.35 billion acquisition of Alif Semiconductor signals a strategic push into the growing AI and edge co…
Apple's Acquisition of Sonera Magnetics: A Bold Move into Neurotechnology
Apple's acquisition of Sonera Magnetics signals a strategic leap into health-tech, reshaping its competitive landscape a…
Intellia's Groundbreaking CRISPR Therapy Receives FDA Priority Review
Intellia's lonvoguran ziclumeran receives FDA Priority Review, positioning NTLA as a leader in CRISPR gene editing.
Merck and Moderna's Game-Changing Melanoma Vaccine Trial Success
A pivotal Phase 3 trial success could reshape the oncology landscape for melanoma treatment, presenting significant inve…
GE Aerospace's $12 Billion Acquisition: A Strategic Move to Enhance Supply Chain Resilience
GE Aerospace is set to acquire Consolidated Precision Products for $12 billion, a strategic move to bolster its defense …
Intellia Therapeutics Advances with FDA Priority Review for Groundbreaking CRISPR Therapy
Intellia Therapeutics secures FDA Priority Review for its CRISPR therapy, potentially transforming the treatment landsca…
Sernova and Seraxis Merge to Form BetaNova Biotherapeutics: A New Player in Type 1 Diabetes Treatment
Sernova and Seraxis merge to create BetaNova, a company poised to innovate in Type 1 diabetes treatment.
International Petroleum Corp Executes Share Buyback as North American Markets Go Dark for Labor Day
IPCO repurchased 140,673 shares under its NCIB while US and Canadian equities closed for Labor Day. Meanwhile, forex mar…